When immunohistochemistry for uPA was performed on the cytology specimens, six of the eight patients (75%) with pancreatic cancer (Figure 1) and two of the 3 patients (67%) with cholangiocarcinoma overexpressed uPA (Figure 2). This evidence concerns the gene PLAU and pancreatic neoplasm.